Intravenous Lidocaine as an Adjuvant for Pain Associated with Sickle Cell Disease.

@article{Nguyen2015IntravenousLA,
  title={Intravenous Lidocaine as an Adjuvant for Pain Associated with Sickle Cell Disease.},
  author={Natalie L Nguyen and Anne M Kome and Denise K Lowe and P. Coylej D. Coyne and Kelly G Hawks},
  journal={Journal of pain & palliative care pharmacotherapy},
  year={2015},
  volume={29 4},
  pages={359-64}
}
The objectives of this study were to evaluate the efficacy and safety of adjuvant intravenous (IV) lidocaine in adults with sickle cell disease (SCD). This was a retrospective review. Adults with SCD receiving at least one IV lidocaine infusion from 2004 to 2014 were included. Patient demographics, lidocaine treatment parameters, pain scores, pain… CONTINUE READING